Xeris Biopharma

XERSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.369 B

$7.93 +7.75%

Close of 7 Aug 2026

Revenue

$291.8M

#2147 by revenue

Earnings

$554.0K

#2419 by earnings

Shares outstanding

182,320,306

Latest filing cover page

P/E ratio

2471.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#143Phibro Animal HealthPAHC$1.39B
#144Lb PharmaceuticalsLBRX$1.38B
#145Xeris BiopharmaXERS$1.37B
#146SchrodingerSDGR$1.36B
#147MoonLake ImmunotherapeuticsMLTX$1.34B

Where these numbers come from

Share counts and financials for Xeris Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.